LSV Asset Management Has $164.97 Million Stake in Cardinal Health, Inc. $CAH

LSV Asset Management reduced its holdings in Cardinal Health, Inc. (NYSE:CAH) by 46.4% in the 2nd quarter, Holdings Channel reports. The fund owned 981,970 shares of the company’s stock after selling 849,442 shares during the quarter. LSV Asset Management’s holdings in Cardinal Health were worth $164,971,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of CAH. Greykasell Wealth Strategies Inc. bought a new position in Cardinal Health in the first quarter valued at approximately $26,000. Jones Financial Companies Lllp boosted its stake in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares during the period. Atlantic Edge Private Wealth Management LLC boosted its stake in Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 75 shares during the period. NewSquare Capital LLC increased its holdings in Cardinal Health by 100.0% during the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock worth $36,000 after purchasing an additional 107 shares in the last quarter. Finally, GW&K Investment Management LLC raised its stake in shares of Cardinal Health by 113.4% in the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after purchasing an additional 144 shares during the period. 87.17% of the stock is owned by institutional investors.

Insider Activity

In related news, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the sale, the insider owned 15,431 shares of the company’s stock, valued at approximately $2,298,293.14. The trade was a 64.59% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Stephen M. Mason sold 41,575 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the transaction, the chief executive officer owned 26,085 shares in the company, valued at approximately $3,881,969.70. This trade represents a 61.45% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is owned by company insiders.

Analyst Ratings Changes

CAH has been the subject of a number of research reports. UBS Group increased their price objective on Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a report on Friday, October 31st. Wells Fargo & Company raised their price target on shares of Cardinal Health from $185.00 to $221.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 5th. Leerink Partners boosted their price objective on shares of Cardinal Health from $187.00 to $211.00 in a research report on Friday, October 31st. Mizuho raised their target price on shares of Cardinal Health from $170.00 to $210.00 and gave the company an “outperform” rating in a research report on Monday, November 3rd. Finally, Jefferies Financial Group set a $220.00 price objective on shares of Cardinal Health and gave the stock a “buy” rating in a research note on Monday, November 3rd. Twelve research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $205.00.

Cardinal Health Stock Performance

Shares of CAH stock opened at $205.35 on Monday. Cardinal Health, Inc. has a 52-week low of $114.60 and a 52-week high of $208.32. The stock has a market cap of $48.79 billion, a price-to-earnings ratio of 31.84, a PEG ratio of 1.39 and a beta of 0.72. The firm’s 50-day moving average is $165.58 and its 200-day moving average is $159.21.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. During the same quarter in the previous year, the business earned $1.88 earnings per share. The business’s revenue was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Sell-side analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a dividend of $0.5107 per share. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $2.04 annualized dividend and a yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.